Rivero Mestre’s experienced and innovative class action litigators have achieved outstanding results both defending and prosecuting class actions in federal and state courts throughout the United States. We have been honored as class action firm of the year by the Daily Business Review in its 13th Annual Most Effective Lawyers special report.
Our lawyers are experienced in complex class action cases, including multidistrict litigation, involving a variety of legal areas such as:
The firm and its lawyers have been court-appointed as lead class counsel, liaison counsel, members of executive committees in a multitude of class action cases. We have obtained exceptional results for our clients, more than $600 million in healthcare benefits obtained from settlements with Centene Corporation, Inc.; Blue Cross and Blue Shield of Florida Inc.; and UnitedHealthcare on behalf of classes of individuals suffering from the life-threatening disease hepatitis C. Our partners have been named recently as co-lead counsel or to the Plaintiffs’ Executive Committee in matters such as In re Valsartan, Losartan, and Irbesartan Products Liability Litigation, a multidistrict proceeding involving the largest Class I pharmaceutical drug recall of the second-most prescribed blood pressure medicines in the United States and In re Metformin Marketing and Sales Practices Litigation, representing third-party payers against several manufacturers and distributors of Metformin, the most prescribed type II diabetes drug in the United States.
M.D. v. Centene Corp.
Rivero Mestre sued Centene Corporation, Inc. (Centene) in June 2018, for failing to provide members of the class with the cure that would save their lives—Harvoni. Centene—the largest health insurer in the multistate marketplace for individual health insurance policies created under the Patient Protection and Affordable Care Act—had set up pretextual guidelines that resulted in the denial of Harvoni coverage for patients suffering from the most acute cases of hepatitis C. The instructions went so far as to refuse coverage unless an insured sought duplicative tests that were either difficult to obtain because they aren’t readily available or potentially damaging to the precarious health of Centene’s insureds. We obtained $141 million worth of life-saving treatment for a class of 1500 hepatitis C sufferers in a settlement with Centene Corp. In addition to the $141 million of insurance coverage, the settlement also provides a fund to pay for insurance coverage for a subset of persons no longer insured by Centene so that they can obtain the treatment they need.
Oakes v. Blue Cross & Blue Shield of Florida, Inc.
Rivero Mestre sued Blue Cross and Blue Shield of Florida, Inc. (collectively, “Florida Blue”) in January 2016, to provide members of the class with the cure that would save their lives—Harvoni. The FDA approved Harvoni in October 2014 and gave it the rare “breakthrough therapy” label. It cures hepatitis C in 99% of the cases with almost no side effects. The cure, however, comes with a steep price tag (starting at $63,000 for the shortest course of treatment), which caused insurers to come up with schemes to deny coverage. Rivero Mestre successfully obtained more than $200 million in benefits on behalf of more than 2,500 individuals in a settlement with Florida Blue in a highly contests class action.
Jones v. UnitedHealth Group, Inc.
Rivero Mestre sued United HealthCare Services Inc. (“United”) in May 2015, to provide members of the class with the cure that would save their lives—Harvoni. The FDA approved Harvoni in October 2014 and gave it the rare “breakthrough therapy” label. It cures hepatitis C in 99% of the cases with almost no side effects. The cure, however, comes with a steep price tag (starting at $63,000 for the shortest course of treatment), which caused insurers to come up with schemes to deny coverage. Rivero Mestre successfully obtained nearly $300 million in benefits on behalf of more than 4,000 in a settlement with United in a highly contests class action.
In re: Valsartan Products Liability Litigation
Rivero Mestre has sued various generic pharmaceutical manufacturers because they sold carcinogen-tainted Valsartan—a generic version of the leading blood pressure medicine in the U.S.—into the United States. The Valsartan contamination case deals with extremely disturbing corporate misconduct that has caused the single largest FDA recall ever. Rivero Mestre filed its case in Miami, Florida, on behalf of third-party payors (medical insurers) who have paid as much as 80% of the estimated $3 billion cost of the tainted Valsartan and the untainted replacement doses of the recalled Valsartan. Because hundreds of individual injury cases were expected, the case was drawn into the multi-district litigation (MDL) process, which led to the consolidation of all cases in Camden, New Jersey. Rivero Mestre has been named to the executive committee leadership of the MDL and is lead counsel on the third-party payor issues in the MDL. The MDL is entering the discovery stage and the TPP issues are expected to be among the earlier aspects of the litigation to be addressed by the Court.
Mata v. Trivago GMBH; Lopez Regueiro v. American Airlines Inc.; and Del Valle v. Trivago GMBH
Rivero Mestre has aggressively pursued claims under the Helms-Burton statute since Title III of the law was allowed to go into effect by order of the U.S. president on May 2, 2019. The law allows U.S. nationals to claim damages against persons who “traffic” in property they (or their forbearers) owned in Cuba at the time of the Cuban revolution that was thereafter confiscated by the Castro government. On learning that the statute had become operational Rivero Mestre quickly analyzed potential cases (determining that economic activities like tourism, transportation, rum and mining were most likely to be the basis for successful suits) and brought the greatest number and most important of the 20 lawsuits filed at the time of this submission. Rivero Mestre has sued the principal hotel chains operating in Cuba, bringing 5 hotel-related lawsuits relating to more than 70 of the 84 foreign hotels operating in Cuba. The largest such case names Melia International S.A, which operates 34 hotels and resorts in Cuba and the online reservation bookings services, Expedia, and Booking.com. Rivero Mestre has also brought the single biggest claim, that of the heir to the Jose Marti International Airport, against two of the major airlines flying into that airport. The Jose Marti International airport claim is estimated to be for an amount approaching $1 billion. All of the cases are extraordinarily complex, involving questions of proof spanning six decades, conduct crossing multiple borders, and legal questions of first impression because the statute has never been applied until now.
Hildenbrand v. W Holding Co., Inc.
We represented former directors and officers of W Holding Co., Inc. in a securities class action lawsuit, Hildenbrand v. W Holding Co., Inc., in the U.S. District Court for Puerto Rico. Filed on behalf of purchasers of the publicly-traded securities of W Holding, the suit alleged that W Holding violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 and SEC Rule 10b-5. We opposed class certification, moved for sanctions against the lead plaintiff and his counsel—the largest class action firm in the U.S.—and ultimately moved for summary judgment, all of which caused the plaintiff to settle for pennies on the dollar. We whittled a claim of $135 million to a settlement of $8.75 million, which the available D&O insurance amply .
Anwar v. Fairfield Greenwich Limited
Rivero Mestre represented Headway in the multi-district lawsuit arising from the Bernie Madoff fraud scheme. Headway sued Standard Chartered Bank (SCB) because it recommended that Headway invest millions of dollars in two investment funds offered by Fairfield Greenwich that were nothing more than funnels into Madoff’s coffers. The Court appointed Jorge Mestre to the Plaintiffs’ Steering Committee. SCB, represented by Sullivan & Cromwell, moved to dismiss the claims based on the Securities Litigation Uniform Standards Act (SLUSA). On July 29, 2015, the Court ruled that Headway’s claims related to SCB’s failure to conduct due diligence—the essence of the claim—are not barred by SLUSA. In light of this critical ruling in Headway’s favor, the case was set for trial and a favorable settlement was obtained after years of litigation.
Sicilia v. Home Title Association, Inc.
We defended Home Title in a class action alleging that it was charging title premiums that exceeded those permitted under Florida law to Florida consumers who were refinancing their mortgages and obtained a dismissal.
Nov 30, 2020
MIAMI— Rivero Mestre is pleased to announce that Neha Dagley co-edited The Florida Bar International Law Section publication, International Law Quarterly, Vol. XXXVI, no. 3 (World Roundup and Section Scene). She also published three short articles, China’s new National Security Law overshadows freedoms for Hong Kong, Supreme Court of India enforces foreign arbitral award under […]
Nov 17, 2020
MIAMI—Jorge A. Mestre will speak about International Arbitration and Technology at the Legalink Members’ General e-Meetings on Thursday, November 19. Mestre will speak on a panel entitled, “Resolving Technology Disputes Through Arbitration And The Use Of Technology In Arbitral Proceedings.” Legalink is a Chambers-ranked, international legal Network of over 70 independent business oriented law firms […]
Nov 5, 2020
MIAMI—Rivero Mestre LLP is proud to announce that U.S. News & World Report—Best Lawyers® has ranked the firm in Tier 1 of the “Best Law Firms” for Commercial Litigation, Litigation—Securities, Litigation—Banking & Finance, and Criminal Defense: White-Collar in Metropolitan Miami. “We are honored to be recognized as a top tier law firm by our peers […]
Oct 6, 2020
MIAMI—Rivero Mestre is proud to announce that the firm has been ranked in the 2021 edition of Benchmark Litigation in Dispute Resolution as a “Highly Recommended Firm” in Florida. Benchmark also recognized partners Andrés Rivero, Jorge A. Mestre, Amanda McGovern, and Maria Paula Aguila as Florida “Local Litigation Stars.” Benchmark Litigation, which focuses exclusively on the […]
Sep 30, 2020
MIAMI—Bryan L. Paschal was featured in “On the Rise” question and answer series by the Daily Business Review. Paschal shared his journey to a career in law, his proudest achievements, and his goals for next year. The DBR’s On the Rise program recognizes the region’s most promising lawyers under the age of 40. The award […]
Sep 24, 2020
MIAMI—Rivero Mestre is extremely pleased, honored, and proud to announce that we have been recognized by Chambers as the 2020 “Outstanding Firm for Furthering Diversity and Inclusion” in the United States. We are particularly pleased to have been selected from a group of 23 nominees, including some of the largest firms in the world, as […]
Sep 16, 2020
MIAMI—Rivero Mestre LLP proudly announces that Zalman Kass has been named a partner at the firm. “Zalman is an excellent lawyer and also a highly effective leader within the firm,” said Andres Rivero. “He is perfectly aligned with our strategic goals of growth and game changing service, and we are excited to see him in […]
Sep 15, 2020
MIAMI—Rivero Mestre is proud to announce that Jorge A. Mestre has been recognized by the Florida Bar as Board Certified in International Litigation and Arbitration. The purpose of the International Litigation and Arbitration Certification is to identify those lawyers who have the special knowledge, skills, and proficiency, as well as the character, ethics, and reputation for […]
Sep 11, 2020
MIAMI— Law360 reported on Rivero Mestre’s groundbreaking result on September 4, 2020, where the United States Court of Appeals for the Eleventh Circuit ruled that down-stream entities, such as provider networks, that ultimately bear the financial risk in administering Medicare benefits through their contracts with Medicare Advantage Organization can sue primary payers for nonpayment under […]
Sep 3, 2020
MIAMI—Rivero Mestre is proud to announce its launch of a new podcast, The Litigation Room: Where it Happens. In each episode, we will discuss pressing business developments and practical considerations about how to approach complex litigation problems. The podcast is available on Spotify, Anchor, YouTube, Breaker, Pocket Casts, Google Podcasts, RadioPublic, Apple Podcasts, and, coming […]
Aug 24, 2020
MIAMI—Rivero Mestre LLP is proud to announce Andrés Rivero, Jorge A. Mestre, Amanda McGovern, and Alan H. Rolnick are featured in the 2021 edition of The Best Lawyers in America©. They were selected through a sophisticated peer-review process that surveys leading lawyers about the professional abilities of their colleagues in the same geographic and legal […]
Aug 13, 2020
MIAMI—Rivero Mestre is proud to announce that Amanda McGovern has been recognized in The Best Lawyers in America© “Women in the Law” Business Edition. Amanda McGovern was recognized for her work in Commercial Litigation; Corporate Law; and Securities/Capital Markets Law. Amanda McGovern has been recognized repeatedly as a top litigator in matters that are both […]